No abstract available
Keywords:
Recurrent respiratory papillomatosis; adverse effect; bevacizumab; laryngeal application; pyogenic granuloma.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Mucosal
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects*
-
Angiogenesis Inhibitors / therapeutic use
-
Bevacizumab / administration & dosage
-
Bevacizumab / adverse effects*
-
Bevacizumab / therapeutic use
-
Child, Preschool
-
Female
-
Granuloma, Pyogenic / chemically induced*
-
Humans
-
Laryngoscopy
-
Papillomavirus Infections / drug therapy*
-
Respiratory Tract Infections / drug therapy*
-
Tracheal Diseases / chemically induced*
Substances
-
Angiogenesis Inhibitors
-
Bevacizumab
Supplementary concepts
-
Recurrent respiratory papillomatosis